Baxter (BAX) Q4 Earnings: Revenue Up 5% Y/Y, EPS Estimate $0.54/share

Baxter International (NYSE:BAX) reports earnings Thursday before market open. Fourth-quarter revenue is expected to rise 2.2% year-on-year to $2.81 billion, up from $2.84 billion in Q4 2024, while adjusted EPS is forecast at $0.54 per share. The company missed revenue guidance and full-year EPS expectations, and its Q4 revenue fell 1.4% versus the prior period. Analysts have confirmed estimates recently, while the broader medical devices and supplies sector underperformed last month (-3.7%) versus Baxter’s +8.3% and an average price target of $22.90 versus its current $21.82 share price.